UniProt ID | ELF3_HUMAN | |
---|---|---|
UniProt AC | P78545 | |
Protein Name | ETS-related transcription factor Elf-3 | |
Gene Name | ELF3 {ECO:0000312|HGNC:HGNC:3318} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 371 | |
Subcellular Localization | Cytoplasm . Nucleus . Localizes to the cytoplasm where it has been shown to transform MCF-12A mammary epithelial cells via a novel cytoplasmic mechanism. Also transiently expressed and localized to the nucleus where it induces apoptosis in non-transf | |
Protein Description | Transcriptional activator that binds and transactivates ETS sequences containing the consensus nucleotide core sequence GGA[AT]. Acts synergistically with POU2F3 to transactivate the SPRR2A promoter and with RUNX1 to transactivate the ANGPT1 promoter. Also transactivates collagenase, CCL20, CLND7, FLG, KRT8, NOS2, PTGS2, SPRR2B, TGFBR2 and TGM3 promoters. Represses KRT4 promoter activity. Involved in mediating vascular inflammation. May play an important role in epithelial cell differentiation and tumorigenesis. May be a critical downstream effector of the ERBB2 signaling pathway. May be associated with mammary gland development and involution. Plays an important role in the regulation of transcription with TATA-less promoters in preimplantation embryos, which is essential in preimplantation development (By similarity).. | |
Protein Sequence | MAATCEISNIFSNYFSAMYSSEDSTLASVPPAATFGADDLVLTLSNPQMSLEGTEKASWLGEQPQFWSKTQVLDWISYQVEKNKYDASAIDFSRCDMDGATLCNCALEELRLVFGPLGDQLHAQLRDLTSSSSDELSWIIELLEKDGMAFQEALDPGPFDQGSPFAQELLDDGQQASPYHPGSCGAGAPSPGSSDVSTAGTGASRSSHSSDSGGSDVDLDPTDGKLFPSDGFRDCKKGDPKHGKRKRGRPRKLSKEYWDCLEGKKSKHAPRGTHLWEFIRDILIHPELNEGLMKWENRHEGVFKFLRSEAVAQLWGQKKKNSNMTYEKLSRAMRYYYKREILERVDGRRLVYKFGKNSSGWKEEEVLQSRN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
58 | Phosphorylation | LEGTEKASWLGEQPQ CCCCCCCHHCCCCCC | 33.62 | 28348404 | |
68 | Phosphorylation | GEQPQFWSKTQVLDW CCCCCCCCHHHHHHH | 27.41 | - | |
82 | Ubiquitination | WISYQVEKNKYDASA HHHHHHHHCCCCCCC | 60.94 | 21906983 | |
82 (in isoform 2) | Ubiquitination | - | 60.94 | 21906983 | |
82 (in isoform 1) | Ubiquitination | - | 60.94 | 21906983 | |
84 | Ubiquitination | SYQVEKNKYDASAID HHHHHHCCCCCCCCC | 56.42 | 21906983 | |
84 (in isoform 1) | Ubiquitination | - | 56.42 | 21906983 | |
84 (in isoform 2) | Ubiquitination | - | 56.42 | 21906983 | |
137 | Phosphorylation | SSSSDELSWIIELLE CCCHHHHHHHHHHHH | 17.74 | 28348404 | |
183 (in isoform 2) | Phosphorylation | - | 17.52 | 27762562 | |
184 (in isoform 2) | Phosphorylation | - | 5.55 | 27762562 | |
206 | Phosphorylation | AGTGASRSSHSSDSG CCCCCCCCCCCCCCC | 29.88 | 23663014 | |
207 | Phosphorylation | GTGASRSSHSSDSGG CCCCCCCCCCCCCCC | 26.69 | 17491012 | |
209 | Phosphorylation | GASRSSHSSDSGGSD CCCCCCCCCCCCCCC | 37.48 | 23663014 | |
210 | Phosphorylation | ASRSSHSSDSGGSDV CCCCCCCCCCCCCCC | 30.30 | 23663014 | |
212 | Phosphorylation | RSSHSSDSGGSDVDL CCCCCCCCCCCCCCC | 47.18 | 28355574 | |
215 | Phosphorylation | HSSDSGGSDVDLDPT CCCCCCCCCCCCCCC | 37.68 | 28355574 | |
222 | Phosphorylation | SDVDLDPTDGKLFPS CCCCCCCCCCCCCCC | 57.98 | 28176443 | |
254 | Phosphorylation | RGRPRKLSKEYWDCL CCCCCCCCHHHHHHH | 26.86 | 25394399 | |
257 | Phosphorylation | PRKLSKEYWDCLEGK CCCCCHHHHHHHCCC | 15.41 | 30576142 | |
264 | Ubiquitination | YWDCLEGKKSKHAPR HHHHHCCCCCCCCCC | 44.49 | - | |
271 (in isoform 2) | Ubiquitination | - | 64.52 | 21906983 | |
294 (in isoform 1) | Ubiquitination | - | 57.30 | 21906983 | |
294 | Ubiquitination | ELNEGLMKWENRHEG HHCCCHHHCCCCCHH | 57.30 | 21906983 | |
295 (in isoform 2) | Ubiquitination | - | 8.30 | 21906983 | |
304 | Acetylation | NRHEGVFKFLRSEAV CCCHHHHHHHHHHHH | 40.87 | 30588473 | |
305 (in isoform 2) | Ubiquitination | - | 4.68 | 21906983 | |
308 | Phosphorylation | GVFKFLRSEAVAQLW HHHHHHHHHHHHHHH | 31.86 | - | |
318 | "N6,N6-dimethyllysine" | VAQLWGQKKKNSNMT HHHHHCCCCCCCCCC | 62.87 | - | |
318 | Ubiquitination | VAQLWGQKKKNSNMT HHHHHCCCCCCCCCC | 62.87 | 21906983 | |
318 | Methylation | VAQLWGQKKKNSNMT HHHHHCCCCCCCCCC | 62.87 | - | |
318 (in isoform 1) | Ubiquitination | - | 62.87 | 21906983 | |
319 | "N6,N6-dimethyllysine" | AQLWGQKKKNSNMTY HHHHCCCCCCCCCCH | 49.66 | - | |
319 | Methylation | AQLWGQKKKNSNMTY HHHHCCCCCCCCCCH | 49.66 | - | |
320 | Methylation | QLWGQKKKNSNMTYE HHHCCCCCCCCCCHH | 73.05 | - | |
320 | "N6,N6-dimethyllysine" | QLWGQKKKNSNMTYE HHHCCCCCCCCCCHH | 73.05 | - | |
322 | Phosphorylation | WGQKKKNSNMTYEKL HCCCCCCCCCCHHHH | 36.54 | 29396449 | |
325 | Phosphorylation | KKKNSNMTYEKLSRA CCCCCCCCHHHHHHH | 32.55 | 29396449 | |
326 | Phosphorylation | KKNSNMTYEKLSRAM CCCCCCCHHHHHHHH | 10.57 | 29396449 | |
328 | Ubiquitination | NSNMTYEKLSRAMRY CCCCCHHHHHHHHHH | 41.15 | 21906983 | |
328 (in isoform 1) | Ubiquitination | - | 41.15 | 21906983 | |
333 (in isoform 2) | Ubiquitination | - | 2.48 | 21906983 | |
339 (in isoform 2) | Ubiquitination | - | 21.77 | 21906983 | |
356 (in isoform 1) | Ubiquitination | - | 57.71 | 21906983 | |
356 | Ubiquitination | RLVYKFGKNSSGWKE EEEEECCCCCCCCCH | 57.71 | 21906983 | |
362 (in isoform 1) | Ubiquitination | - | 59.79 | 21906983 | |
362 | Ubiquitination | GKNSSGWKEEEVLQS CCCCCCCCHHHHHHC | 59.79 | 2190698 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ELF3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ELF3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...